Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-078724)

Filing Details

Accession Number:: 0001209191-15-078724
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-11-05 16:47:10
Reporting Period:: 2015-11-03

Filing Date:: 2015-11-05
Accepted Time:: 2015-11-05 16:47:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879169	Incyte Corp	INCY	Services-Commercial Physical & Biological Research (8731)	943136539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1624033	Yao Wenqing	1801 Augustine Cut-Off Wilmington DE 19803	Evp, Discovery Medicinal And P	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-11-03	786	$124.95	21,371	No	4	S	Direct
Common Stock	Acquisiton	2015-11-03	5,000	$17.79	26,371	No	4	M	Direct
Common Stock	Disposition	2015-11-03	5,000	$124.75	21,371	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-11-03	5,000	$0.00	5,000	$17.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,354		2019-01-18	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.